Articles dans des revues avec comité de lecture (187)
  1. 97. Leroy, K., Duyckaerts, C., Bovekamp, L., Müller, O., Anderton, B., & Brion, J. P. (2001). Increase of adenomatous polyposis coli immunoreactivity is a marker of reactive astrocytes in Alzheimer's disease and in other pathological conditions. Acta Neuropathologica, 102(1), 1-10.
  2. 98. Anderton, B., Betts, J., Blackstock, W. P., Brion, J. P., Chapman, S. J., Connell, J., Dayanandan, R., Gallo, J. M., Gibb, G. M., Hanger, D., Hutton, M., Kardalinou, E., Leroy, K., Lovestone, S., Mack, T. G., Reynolds, C. H., & Van Slegtenhorst, M. (2001). Sites of phosphorylation in tau and factors affecting their regulation. Biochemical Society Symposia,(67), 73-80.
  3. 99. Brion, J. P., Anderton, B., Authelet, M., Dayanandan, R., Leroy, K., Lovestone, S., Octave, J. N., Pradier, L., Touchet, N., & Tremp, G. (2001). Neurofibrillary tangles and tau phosphorylation. Biochemical Society Symposia,(67), 81-88.
  4. 100. Toussaint, O., Baret, P. V., Brion, J. P., Cras, P., Collette, F., De Deyn, P. P., Geenen, V., Kienlen-Campard, P. K., Labeur, C., Legros, J. J., Neve, J., Octave, J. N., Piérard, G. E., Salmon, E., van den Bosch de Aguilar P, P., Van der Linden, M., Leuven, F. V., & Vanfleteren, J. (2000). Experimental gerontology in Belgium: from model organisms to age-related pathologies. Experimental gerontology, 35(8), 901-916.
  5. 101. Leroy, K., Menu, R., Conreur, J. L., Dayanandan, R., Lovestone, S., Anderton, B., & Brion, J. P. (2000). The function of the microtubule-associated protein tau is variably modulated by graded changes in glycogen synthase kinase-3beta activity. FEBS letters, 465(1), 34-38.
  6. 102. Brion, J. P. (2000). Neuropathologie de la substance blanche. Radiologie, 20(5), 203-208.
  7. 103. Leroy, K., & Brion, J. P. (1999). Developmental expression and localization of glycogen synthase kinase-3beta in rat brain. Journal of chemical neuroanatomy, 16(4), 279-293.
  8. 104. McLoughlin, D. M., Irving, N. G., Brownlees, J., Brion, J. P., Leroy, K., & Miller, C. C. (1999). Mint2/X11-like colocalizes with the Alzheimer's disease amyloid precursor protein and is associated with neuritic plaques in Alzheimer's disease. European journal of neuroscience, 11(6), 1988-1994. doi:10.1046/j.1460-9568.1999.00610.x
  9. 105. Lovestone, S., Davis, D. R., Webster, M. T., Kaech, S., Brion, J. P., Matus, A., & Anderton, B. (1999). Lithium reduces tau phosphorylation: effects in living cells and in neurons at therapeutic concentrations. Biological psychiatry, 45(8), 995-1003.
  10. 106. Dayanandan, R., Van Slegtenhorst, M., Mack, T. G., Ko, L., Yen, S. H., Leroy, K., Brion, J. P., Anderton, B., Hutton, M., & Lovestone, S. (1999). Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation. FEBS letters, 446(2-3), 228-232. doi:10.1016/S0014-5793(99)00222-7
  11. 107. Brion, J. P. (1999). Dégénérescences neurofibrillaires et modifications précoces du cytosquelette neuronal dans la maladie d'Alzheimer et dans des modèles expérimentaux. Bulletin et mémoires de l'Académie royale de médecine de Belgique, 154(6 Pt 2), 287-294.
  12. 108. Brion, J. P., Tremp, G., & Octave, J. N. (1999). Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease. The American journal of pathology, 154(1), 255-270.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Suivant >>